Single-nucleotide Polymorphism of CD36 Locus and Obesity in European Adolescents

被引:55
作者
Bokor, Szilvia [1 ]
Legry, Vanessa [1 ]
Meirhaeghe, Aline [1 ]
Ruiz, Jonatan R. [2 ,3 ]
Mauro, Beatrice [4 ]
Widhalm, Kurt [5 ]
Manios, Yannis [6 ]
Amouyel, Philippe [1 ]
Moreno, Luis A. [7 ]
Molnar, Denes [8 ]
Dallongeville, Jean [1 ]
机构
[1] Univ Lille Nord France, UDSL, Dept Epidemiol & Publ Hlth, Inst Pasteur Lille,INSERM,U744, Lille, France
[2] Karolinska Inst, Unit Prevent Nutr, Dept Biosci & Nutr, Novum, Stockholm, Sweden
[3] Univ Granada, Dept Physiol, Sch Med, Granada, Spain
[4] Natl Res Inst Food & Nutr, Res Dept, INRAN, Rome, Italy
[5] Med Univ Vienna, Dept Pediat, Div Clin Nutr & Prevent, Vienna, Austria
[6] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece
[7] Univ Zaragoza, GENUD Growth Exercise Nutr & Dev Res Grp, Escuela Univ Ciencias Salud, Zaragoza, Spain
[8] Univ Pecs, Dept Pediat, Pecs, Hungary
关键词
GENOME-WIDE ASSOCIATION; HUMAN ADIPOSE-TISSUE; HEALTHY LIFE-STYLE; FATTY-ACID; PROMOTER POLYMORPHISM; INSULIN-RESISTANCE; GENE-EXPRESSION; OXIDIZED LDL; EARLY-ONSET; PPAR-GAMMA;
D O I
10.1038/oby.2009.412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CD36 is a membrane receptor with a wide variety of functions, including the regulation of energy metabolism, fat storage, and adipocyte differentiation. To assess the relationship between CD36 gene single-nucleotide polymorphisms (SNPs) and obesity in adolescents, we evaluated the relationship between CD36 SNPs and the risk of obesity in a case-control study composed of 307 obese (age = 15.0 +/- 1.1 years) and 339 normal-weight adolescents (age = 14.6 +/- 1.1 years). To validate the results, we assessed the relation between the same SNPs and percentage of body fat (BF%) and BMI in 1,151 European adolescents (age = 14.8 +/- 1.4 years). SNPs with a minor allele frequency >0.10 were selected to tag CD36. Genotyping was performed on an Illumina system. Four SNPs (rs3211867, rs3211883, rs3211908, and rs1527483) were associated with increased risk of obesity in the case-control study (odds ratio (OR) (95% confidence interval)): 1.96 (1.26-3.04], P = 0.003; 1.73 (1.16-2.59), P = 0.007; 2.42 (1.47-4.01), P = 0.0005 and 1.95 (1.25-3.05), P = 0.003, respectively). The same four SNPs were associated with higher BMI (P < 0.05) and BF% (P < 0.04) in the validation study. Further analyses identified a haplotype (frequency: 0.05) carrying the minor allele of these SNPs as being associated with obesity (OR: 2.28; P = 0.0008) in the case-control study and with excess adiposity (i.e., higher BF% (P = 0.03) and BMI (P = 0.04)) in the validation study. Our data suggest that genetic variability at the CD36 gene locus could be associated with body weight variability in European adolescents but these findings require replication.
引用
收藏
页码:1398 / 1403
页数:6
相关论文
共 38 条
  • [1] Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA Cross-Sectional Study
    Beghin, L.
    Castera, M.
    Manios, Y.
    Gilbert, C. C.
    Kersting, M.
    De Henauw, S.
    Kafatos, A.
    Gottrand, F.
    Molnar, D.
    Sjostrom, M.
    Leclercq, C.
    Widhalm, K.
    Mesana, M. I.
    Moreno, L. A.
    Libersa, C.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (Suppl 5) : S12 - S18
  • [2] Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36
    Bonen, A
    Parolin, ML
    Steinberg, GR
    Calles-Escandon, J
    Tandon, NN
    Glatz, JFC
    Luiken, JJFP
    Heigenhauser, GJF
    Dyck, DJ
    [J]. FASEB JOURNAL, 2004, 18 (07) : 1144 - +
  • [3] Matlnspector and beyond: promoter analysis based on transcription factor binding sites
    Cartharius, K
    Frech, K
    Grote, K
    Klocke, B
    Haltmeier, M
    Klingenhoff, A
    Frisch, M
    Bayerlein, M
    Werner, T
    [J]. BIOINFORMATICS, 2005, 21 (13) : 2933 - 2942
  • [4] Establishing a standard definition for child overweight and obesity worldwide: international survey
    Cole, TJ
    Bellizzi, MC
    Flegal, KM
    Dietz, WH
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7244): : 1240 - 1243
  • [5] Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance
    Corpeleijn, E.
    van der Kallen, C. J. H.
    Kruijshoop, M.
    Magagnin, M. G. P.
    de Bruin, T. W. A.
    Feskens, E. J. M.
    Saris, W. H. M.
    Blaak, E. E.
    [J]. DIABETIC MEDICINE, 2006, 23 (08) : 907 - 911
  • [6] Hexarelin Signaling to PPARγ in Metabolic Diseases
    Demers, Annie
    Rodrigue-Way, Amelie
    Tremblay, Andre
    [J]. PPAR RESEARCH, 2008, 2008
  • [7] A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
    Febbraio, M
    Abumrad, NA
    Hajjar, DP
    Sharma, K
    Cheng, WL
    Pearce, SFA
    Silverstein, RL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) : 19055 - 19062
  • [8] CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
    Febbraio, M
    Hajjar, DP
    Silverstein, RL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (06) : 785 - 791
  • [9] CD36: Implications in cardiovascular disease
    Febbraio, Maria
    Silverstein, Roy L.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (11) : 2012 - 2030
  • [10] Effects of obesity and weight loss on the expression of proteins involved in fatty acid metabolism in human adipose tissue
    Fisher, RM
    Hoffstedt, J
    Hotamisligil, GS
    Thörne, A
    Rydén, M
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (10) : 1379 - 1385